Docoh
Loading...

MRSN Mersana Therapeutics

APP
Utility
NAPI2B-TARGETED Antibody-drug Conjugates and Methods of Use Thereof
30 Sep 21
This disclosure provides NaPi2b-targeted antibody-drug conjugates (e.g., NaPi2b-targeted antibody-polymer-drug conjugates) that specifically bind to the extracellular region of SLC34A2, and to methods of using such conjugates in a variety of therapeutic, diagnostic, and prophylactic indications.
Donald A. BERGSTROM, Natalya D. BODYAK, Timothy B. LOWINGER, Peter U. PARK, Laura L. POLING, Aleksandr V. YURKOVETSKIY
Filed: 20 Jan 21
APP
Utility
Site Specific Antibody-drug Conjugates with Peptide-containing Linkers
22 Jul 21
The present disclosure relates generally to antibody-drug conjugates comprising peptide-containing linkers and to methods of using these conjugates as therapeutics and/or diagnostics.
Timothy B. LOWINGER, Marc I. DAMELIN, Dorin TOADER
Filed: 8 Jan 21
APP
Utility
Sting Agonist Compounds and Methods of Use
4 Feb 21
The present disclosure relates to STING (Stimulator of Interferon Genes) agonist compounds, methods of making the compounds and their methods of use.
Jeremy R. DUVALL, Keith W. BENTLEY, Brian D. JONES, Eugene W. KELLEHER, Soumya S. RAY, Joshua D. THOMAS, Dorin TOADER
Filed: 31 Jul 20
APP
Utility
NaPi2B-TARGETED POLYMER ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF
19 Feb 20
Disclose herein are dosing regimens for targeted NaPi2b antibody-drug conjugates for treating cancer.
Eric P. HAILMAN, Donna M. JARLENSKI, Donald A. BERGSTROM
Filed: 15 Aug 19
APP
Utility
Monoclonal Antibodies Against HER2 Epitope and Methods of Use Thereof
29 Jan 20
This invention provides fully human monoclonal antibodies that recognize HER2.
Natalya D. BODYAK, Michael J. DeVIT, Eric M. KRAULAND, Timothy B. LOWINGER, Peter U. PARK, Bianka PRINZ, Aleksandr V. YURKOVETSKIY
Filed: 1 Oct 19
  • 1
Patents are sorted by USPTO publication date, most recent first